Projects per year
Personal profile
External positions
Assistant Professor of Medicine, Weill Cornell Medical College
Apr 1 2025 → …
Fingerprint
Dive into the research topics where Akshjot Puri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Puri, A. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Niravath, P. A. (PI), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
7/15/21 → …
Project: Clinical Trial
-
Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Niravath, P. A. (PI), Guan, J. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
2/9/21 → …
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P. (PI), Niravath, P. A. (Key Personnel), Puri, A. (Key Personnel), Sun, K. (Key Personnel) & Templeton, S. (Key Personnel)
Project: Clinical Trial
-
The COVID-19 and Cancer Consortium CCC19 Registry
Zhang, J. (PI), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
Project: Clinical Trial
-
Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer
Puri, A., Yin, Z., Granados-Principal, S., Ensor, J., Guzman, L., Rosato, R., Zhao, H., Wong, S., Wang, L., Patel, T. & Chang, J. C., 2025, In: International Journal of Breast Cancer. 2025, 1, 8831168.Research output: Contribution to journal › Article › peer-review
Open Access -
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression
Reddy, T., Puri, A., Guzman-Rojas, L., Thomas, C., Qian, W., Zhou, J., Zhao, H., Mahboubi, B., Oo, A., Cho, Y. J., Kim, B., Thaiparambil, J., Rosato, R., Martinez, K. O., Chervo, M. F., Ayerbe, C., Giese, N., Wink, D., Lockett, S. & Wong, S. & 7 others, , Dec 2024, In: Nature Communications. 15, 1, 10737.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
Puri, A., Mylavarapu, C., Xu, J., Patel, T., S.Teh, B., Tremont-Lukats, I., Chang, J. C. & Niravath, P., Jun 2022, In: Breast Cancer Research and Treatment. 193, 3, p. 613-623 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Skeletal metastases in advanced pancreatic ductal adenocarcinoma: A retrospective analysis
Puri, A., Chang, J., Tanner, N., Lucente, P., Desiongco, J., Dragovich, T., Naraev, B. & Kundranda, M., Apr 2021, In: Journal of Gastrointestinal Oncology. 12, 2, p. 455-463 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A rare case of a minimally secretory plasma cell leukemia with a hemorrhagic gastric plasmacytoma
Puri, A., Lau, M. W., Zhao, X. F., Chan, K. C. & Bader, K., 2018, In: Leukemia Research Reports. 9, p. 23-27 5 p.Research output: Contribution to journal › Article › peer-review
Open Access